Dr Reid received funding from Oxagen. All other authors have no conflict of interest
Influence of LRP5 Polymorphisms on Normal Variation in BMD
Article first published online: 7 JUL 2004
Copyright © 2004 ASBMR
Journal of Bone and Mineral Research
Volume 19, Issue 10, pages 1619–1627, October 2004
How to Cite
Koay, M. A., Woon, P. Y., Zhang, Y., Miles, L. J., Duncan, E. L., Ralston, S. H., Compston, J. E., Cooper, C., Keen, R., Langdahl, B. L., MacLelland, A., O'Riordan, J., Pols, H. A., Reid, D. M., Uitterlinden, A. G., Wass, J. A. and Brown, M. A. (2004), Influence of LRP5 Polymorphisms on Normal Variation in BMD. J Bone Miner Res, 19: 1619–1627. doi: 10.1359/JBMR.040704
- Issue published online: 2 DEC 2009
- Article first published online: 7 JUL 2004
- Manuscript Accepted: 18 MAY 2004
- Manuscript Revised: 15 JAN 2004
- Manuscript Received: 31 OCT 2003
- single nucleotide polymorphism;
- LRP5 gene
Genetic studies based on cohorts with rare and extreme bone phenotypes have shown that the LRP5 gene is an important genetic modulator of BMD. Using family-based and case-control approaches, this study examines the role of the LRP5 gene in determining normal population variation of BMD and describes significant association and suggestive linkage between LRP5 gene polymorphisms and BMD in >900 individuals with a broad range of BMD.
Introduction: Osteoporosis is a common, highly heritable condition determined by complex interactions of genetic and environmental etiologies. Genetic factors alone can account for 50–80% of the interindividual variation in BMD. Mutations in the LRP5 gene on chromosome 11q12–13 have been associated with rare syndromes characterized by extremely low or high BMD, but little is known about the contribution of this gene to the development of osteoporosis and determination of BMD in a normal population.
Materials and Methods: To examine the entire spectrum of low to high BMD, 152 osteoporotic probands, their families (597 individuals), and 160 women with elevated BMD (T score > 2.5) were recruited. BMD at the lumbar spine, femoral neck, and hip were measured in each subject using DXA.
Results: PAGE sequencing of the LRP5 gene revealed 10 single nucleotide polymorphisms (SNPs), 8 of which had allele frequencies of >5%, in exons 8, 9, 10, 15, and 18 and in introns 6, 7, and 21. Within families, a strong association was observed between an SNP at nucleotide C171346A in intron 21 and total hip BMD (p < 1 × 10−5 in men only, p = 0.0019 in both men and women). This association was also observed in comparisons of osteoporotic probands and unrelated elevated BMD in women (p = 0.03), along with associations with markers in exons 8 (C135242T, p = 0.007) and 9 (C141759T, p = 0.02). Haplotypes composed of two to three of the SNPs G121513A, C135242T, G138351A, and C141759T were strongly associated with BMD when comparing osteoporotic probands and high BMD cases (p < 0.003). An SNP at nucleotide C165215T in exon 18 was linked to BMD at the lumbar spine, femoral neck, and total hip (parametric LOD scores = 2.8, 2.5, and 2.2 and nonparametric LOD scores = 0.3, 1.1, and 2.2, respectively) but was not genetically associated with BMD variation.
Conclusion: These results show that common LRP5 polymorphisms contribute to the determination of BMD in the general population.